These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26970460)

  • 21. Survey of tuberculosis drug resistance among Tibetan refugees in India.
    Salvo F; Dorjee K; Dierberg K; Cronin W; Sadutshang TD; Migliori GB; Rodrigues C; Trentini F; Di Serio C; Chaisson R; Cirillo DM
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):655-62. PubMed ID: 24903934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study.
    Sharma SK; George N; Kadhiravan T; Saha PK; Mishra HK; Hanif M
    Indian J Med Res; 2009 Oct; 130(4):392-5. PubMed ID: 19942741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidrug-resistant TB in Zambia: review of national data from 2000 to 2011.
    Kapata N; Chanda-Kapata P; Bates M; Mwaba P; Cobelens F; Grobusch MP; Zumla A
    Trop Med Int Health; 2013 Nov; 18(11):1386-91. PubMed ID: 24033538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
    van Maaren PJ
    Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India.
    Sethi S; Mewara A; Dhatwalia SK; Singh H; Yadav R; Singh K; Gupta D; Wanchu A; Sharma M
    BMC Infect Dis; 2013 Mar; 13():137. PubMed ID: 23497169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tuberculosis among household contacts of multidrug-resistant tuberculosis patients in Delhi, India.
    Singla N; Singla R; Jain G; Habib L; Behera D
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1326-30. PubMed ID: 22283889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of drug resistance under the DOTS strategy in Hyderabad, South India, 2001-2003.
    Anuradha B; Aparna S; Hari Sai Priya V; Vijaya Lakshmi V; Akbar Y; Suman Latha G; Murthy KJ
    Int J Tuberc Lung Dis; 2006 Jan; 10(1):58-62. PubMed ID: 16466038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cross-sectional study of tuberculosis drug resistance among previously treated patients in a tertiary hospital in Accra, Ghana: public health implications of standardized regimens.
    Forson A; Kwara A; Kudzawu S; Omari M; Otu J; Gehre F; de Jong B; Antonio M
    BMC Infect Dis; 2018 Apr; 18(1):149. PubMed ID: 29606091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug resistance and associated genetic mutations among patients with suspected MDR-TB in Uttar Pradesh, India.
    Jain A; Singh PK; Chooramani G; Dixit P; Malhotra HS
    Int J Tuberc Lung Dis; 2016 Jul; 20(7):870-5. PubMed ID: 27287637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Has introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?
    Dave P; Vadera B; Kumar AM; Chinnakali P; Modi B; Solanki R; Patel P; Patel P; Pujara K; Nimavat P; Shah A; Bharaswadkar S; Rade K; Parmar M; Nair SA
    PLoS One; 2015; 10(4):e0121996. PubMed ID: 25874545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient and Provider Reported Reasons for Lost to Follow Up in MDRTB Treatment: A Qualitative Study from a Drug Resistant TB Centre in India.
    Deshmukh RD; Dhande DJ; Sachdeva KS; Sreenivas A; Kumar AM; Satyanarayana S; Parmar M; Moonan PK; Lo TQ
    PLoS One; 2015; 10(8):e0135802. PubMed ID: 26301748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Tuberculosis Cascade of Care in India's Public Sector: A Systematic Review and Meta-analysis.
    Subbaraman R; Nathavitharana RR; Satyanarayana S; Pai M; Thomas BE; Chadha VK; Rade K; Swaminathan S; Mayer KH
    PLoS Med; 2016 Oct; 13(10):e1002149. PubMed ID: 27780217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Socio-economical and Clinico-Radiological Profile of 474 MDR TB Cases of a Rural Medical College.
    Jain S; Varudkar HG; Julka A; Singapurwala M; Khosla S; Shah B
    J Assoc Physicians India; 2018 Dec; 66(12):14-18. PubMed ID: 31315318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multidrug-resistant tuberculosis among previously treated patients in the Philippines.
    Gler MT; Macalintal LE; Raymond L; Guilatco R; Quelapio MI; Tupasi TE
    Int J Tuberc Lung Dis; 2011 May; 15(5):652-6. PubMed ID: 21756517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addressing patients' unmet needs related to multidrug-resistant tuberculosis (MDR-TB) care: A qualitative research study from Pune city, India.
    Atre S; Jagtap J; Faqih M; Dumbare Y; Sawant T; Ambike S; Farhat M
    PLoS One; 2023; 18(12):e0295508. PubMed ID: 38153918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and patterns of drug resistant pulmonary tuberculosis in India-A systematic review and meta-analysis.
    Lohiya A; Suliankatchi Abdulkader R; Rath RS; Jacob O; Chinnakali P; Goel AD; Agrawal S
    J Glob Antimicrob Resist; 2020 Sep; 22():308-316. PubMed ID: 32247079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying multidrug resistant tuberculosis transmission hotspots using routinely collected data.
    Manjourides J; Lin HH; Shin S; Jeffery C; Contreras C; Cruz JS; Jave O; Yagui M; Asencios L; Pagano M; Cohen T
    Tuberculosis (Edinb); 2012 May; 92(3):273-9. PubMed ID: 22401962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia.
    Demile B; Zenebu A; Shewaye H; Xia S; Guadie A
    BMC Infect Dis; 2018 May; 18(1):249. PubMed ID: 29855354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The imminent threat of multidrug-resistant tuberculosis in Singapore.
    Chee CB; Khin-Mar KW; Cutter J; Wang YT
    Singapore Med J; 2012 Apr; 53(4):238-40. PubMed ID: 22511044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
    Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.